Literature DB >> 33924978

Interleukin-31 and Pruritic Skin.

Masutaka Furue1, Mihoko Furue2.   

Abstract

Skin inflammation often evokes pruritus, which is the major subjective symptom in many inflammatory skin diseases such as atopic dermatitis and prurigo nodularis. Pruritus or itch is a specific sensation found only in the skin. Recent studies have stressed the pivotal role played by interleukin-31 (IL-31) in the sensation of pruritus. IL-31 is produced by various cells including T helper 2 cells, macrophages, dendritic cells and eosinophils. IL-31 signals via a heterodimeric receptor composed of IL-31 receptor A (IL-31RA) and oncostatin M receptor β. Recent clinical trials have shown that the anti-IL-31RA antibody nemolizumab can successfully decrease pruritus in patients with atopic dermatitis and prurigo nodularis. The IL-31 pathway and pruritic skin are highlighted in this review article.

Entities:  

Keywords:  IL-31; Th2 cell; atopic dermatitis; dendritic cell; itch; macrophage; nemolizumab; prurigo nodularis; pruritus

Year:  2021        PMID: 33924978     DOI: 10.3390/jcm10091906

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  81 in total

Review 1.  Itch and brain.

Authors:  Hideki Mochizuki; Ryusuke Kakigi
Journal:  J Dermatol       Date:  2015-06-05       Impact factor: 4.005

2.  Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages.

Authors:  S Kasraie; M Niebuhr; T Werfel
Journal:  Allergy       Date:  2013-04-27       Impact factor: 13.146

3.  Toll-like receptor-4 signaling mediates pulmonary neutrophil sequestration in response to gram-positive bacterial enterotoxin.

Authors:  Casey M Calkins; Katherine Barsness; Denis D Bensard; Andres Vasquez-Torres; Christopher D Raeburn; Xianzhong Meng; Robert C McIntyre
Journal:  J Surg Res       Date:  2002-05-15       Impact factor: 2.192

4.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

5.  IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.

Authors:  Janine Bilsborough; Donald Y M Leung; Mark Maurer; Michael Howell; Mark Boguniewicz; Mark Boguniewcz; Lena Yao; Harold Storey; Cosette LeCiel; Brandon Harder; Jane A Gross
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

Review 6.  Why we scratch an itch: the molecules, cells and circuits of itch.

Authors:  Diana M Bautista; Sarah R Wilson; Mark A Hoon
Journal:  Nat Neurosci       Date:  2014-01-28       Impact factor: 24.884

Review 7.  Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.

Authors:  M Furue; K Yamamura; M Kido-Nakahara; T Nakahara; Y Fukui
Journal:  Allergy       Date:  2017-07-20       Impact factor: 13.146

8.  The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction.

Authors:  Kazuhiko Yamamura; Takehito Uruno; Akira Shiraishi; Yoshihiko Tanaka; Miho Ushijima; Takeshi Nakahara; Mayuki Watanabe; Makiko Kido-Nakahara; Ikuya Tsuge; Masutaka Furue; Yoshinori Fukui
Journal:  Nat Commun       Date:  2017-01-09       Impact factor: 14.919

9.  Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation.

Authors:  Bryony Stott; Paul Lavender; Sarah Lehmann; Davide Pennino; Stephen Durham; Carsten B Schmidt-Weber
Journal:  J Allergy Clin Immunol       Date:  2013-05-18       Impact factor: 10.793

10.  IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics.

Authors:  Andrea J Gonzales; Timothy J Fleck; William R Humphrey; Betsy A Galvan; Michelle M Aleo; Sean P Mahabir; Jezaniah-Kira Tena; Karen G Greenwood; Robert B McCall
Journal:  Vet Dermatol       Date:  2015-12-15       Impact factor: 1.589

View more
  5 in total

1.  Current Knowledge on Canine Atopic Dermatitis: Pathogenesis and Treatment.

Authors:  Catherine A Outerbridge; Tyler J M Jordan
Journal:  Adv Small Anim Care       Date:  2021-09-29

Review 2.  Immunotargets and Therapy for Prurigo Nodularis.

Authors:  Angelina Labib; Teresa Ju; Ashley Vander Does; Gil Yosipovitch
Journal:  Immunotargets Ther       Date:  2022-04-26

3.  Special Issue "Pathogenesis, Epidemiology and Treatment of Atopic Dermatitis and Psoriasis".

Authors:  Masutaka Furue
Journal:  J Clin Med       Date:  2021-12-04       Impact factor: 4.241

Review 4.  The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development.

Authors:  Kazufumi Kunimura; Yoshinori Fukui
Journal:  Int Immunol       Date:  2021-11-25       Impact factor: 4.823

5.  High Serum IL-31 Concentration Is Associated with Itch among Renal Transplant Recipients.

Authors:  Piotr K Krajewski; Kinga Tyczyńska; Klaudia Bardowska; Piotr Olczyk; Danuta Nowicka-Suszko; Dariusz Janczak; Hanna Augustyniak-Bartosik; Magdalena Krajewska; Jacek C Szepietowski
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.